664 related articles for article (PubMed ID: 11588219)
1. Regulation of receptor fate by ubiquitination of activated beta 2-adrenergic receptor and beta-arrestin.
Shenoy SK; McDonald PH; Kohout TA; Lefkowitz RJ
Science; 2001 Nov; 294(5545):1307-13. PubMed ID: 11588219
[TBL] [Abstract][Full Text] [Related]
2. beta-arrestin-1 competitively inhibits insulin-induced ubiquitination and degradation of insulin receptor substrate 1.
Usui I; Imamura T; Huang J; Satoh H; Shenoy SK; Lefkowitz RJ; Hupfeld CJ; Olefsky JM
Mol Cell Biol; 2004 Oct; 24(20):8929-37. PubMed ID: 15456867
[TBL] [Abstract][Full Text] [Related]
3. Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the beta2-adrenergic receptor.
Shenoy SK; Xiao K; Venkataramanan V; Snyder PM; Freedman NJ; Weissman AM
J Biol Chem; 2008 Aug; 283(32):22166-76. PubMed ID: 18544533
[TBL] [Abstract][Full Text] [Related]
4. {beta}-Arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase.
Girnita L; Shenoy SK; Sehat B; Vasilcanu R; Girnita A; Lefkowitz RJ; Larsson O
J Biol Chem; 2005 Jul; 280(26):24412-9. PubMed ID: 15878855
[TBL] [Abstract][Full Text] [Related]
5. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
6. Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.
Shenoy SK; Lefkowitz RJ
J Biol Chem; 2003 Apr; 278(16):14498-506. PubMed ID: 12574160
[TBL] [Abstract][Full Text] [Related]
7. Synergistic regulation of beta2-adrenergic receptor sequestration: intracellular complement of beta-adrenergic receptor kinase and beta-arrestin determine kinetics of internalization.
Ménard L; Ferguson SS; Zhang J; Lin FT; Lefkowitz RJ; Caron MG; Barak LS
Mol Pharmacol; 1997 May; 51(5):800-8. PubMed ID: 9145918
[TBL] [Abstract][Full Text] [Related]
8. Mdm2 directs the ubiquitination of beta-arrestin-sequestered cAMP phosphodiesterase-4D5.
Li X; Baillie GS; Houslay MD
J Biol Chem; 2009 Jun; 284(24):16170-16182. PubMed ID: 19372219
[TBL] [Abstract][Full Text] [Related]
9. Beta-arrestin-dependent signaling and trafficking of 7-transmembrane receptors is reciprocally regulated by the deubiquitinase USP33 and the E3 ligase Mdm2.
Shenoy SK; Modi AS; Shukla AK; Xiao K; Berthouze M; Ahn S; Wilkinson KD; Miller WE; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6650-5. PubMed ID: 19363159
[TBL] [Abstract][Full Text] [Related]
10. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types.
Zhang J; Barak LS; Winkler KE; Caron MG; Ferguson SS
J Biol Chem; 1997 Oct; 272(43):27005-14. PubMed ID: 9341139
[TBL] [Abstract][Full Text] [Related]
11. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2.
Wang P; Gao H; Ni Y; Wang B; Wu Y; Ji L; Qin L; Ma L; Pei G
J Biol Chem; 2003 Feb; 278(8):6363-70. PubMed ID: 12488444
[TBL] [Abstract][Full Text] [Related]
12. Distinct roles for β-arrestin2 and arrestin-domain-containing proteins in β2 adrenergic receptor trafficking.
Han SO; Kommaddi RP; Shenoy SK
EMBO Rep; 2013 Feb; 14(2):164-71. PubMed ID: 23208550
[TBL] [Abstract][Full Text] [Related]
13. Beta-adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, beta-arrestin-2, and the ubiquitin-proteasome pathway.
Ogasawara J; Sanpei M; Rahman N; Sakurai T; Kizaki T; Hitomi Y; Ohno H; Izawa T
FASEB J; 2006 Feb; 20(2):350-2. PubMed ID: 16368719
[TBL] [Abstract][Full Text] [Related]
14. Insulin induces heterologous desensitization of G-protein-coupled receptor and insulin-like growth factor I signaling by downregulating beta-arrestin-1.
Dalle S; Imamura T; Rose DW; Worrall DS; Ugi S; Hupfeld CJ; Olefsky JM
Mol Cell Biol; 2002 Sep; 22(17):6272-85. PubMed ID: 12167719
[TBL] [Abstract][Full Text] [Related]
15. GPCR targeting of E3 ubiquitin ligase MDM2 by inactive β-arrestin.
Yun Y; Yoon HJ; Jeong Y; Choi Y; Jang S; Chung KY; Lee HH
Proc Natl Acad Sci U S A; 2023 Jul; 120(28):e2301934120. PubMed ID: 37399373
[TBL] [Abstract][Full Text] [Related]
16. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor.
Goodman OB; Krupnick JG; Santini F; Gurevich VV; Penn RB; Gagnon AW; Keen JH; Benovic JL
Nature; 1996 Oct; 383(6599):447-50. PubMed ID: 8837779
[TBL] [Abstract][Full Text] [Related]
17. Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation.
Liang W; Fishman PH
J Biol Chem; 2004 Nov; 279(45):46882-9. PubMed ID: 15331590
[TBL] [Abstract][Full Text] [Related]
18. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.
Luttrell LM; Ferguson SS; Daaka Y; Miller WE; Maudsley S; Della Rocca GJ; Lin F; Kawakatsu H; Owada K; Luttrell DK; Caron MG; Lefkowitz RJ
Science; 1999 Jan; 283(5402):655-61. PubMed ID: 9924018
[TBL] [Abstract][Full Text] [Related]
19. Arrestin domain-containing protein 3 recruits the NEDD4 E3 ligase to mediate ubiquitination of the beta2-adrenergic receptor.
Nabhan JF; Pan H; Lu Q
EMBO Rep; 2010 Aug; 11(8):605-11. PubMed ID: 20559325
[TBL] [Abstract][Full Text] [Related]
20. Binding of purified recombinant beta-arrestin to guanine-nucleotide-binding-protein-coupled receptors.
Söhlemann P; Hekman M; Puzicha M; Buchen C; Lohse MJ
Eur J Biochem; 1995 Sep; 232(2):464-72. PubMed ID: 7556195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
